TissUse is a pioneering force in multi-organ-chip technology, driving innovation since 2010. Our HUMIMIC platform transforms preclinical research by accurately simulating complex human organ interactions, providing researchers with predictive, data-rich insights into drug safety, efficacy, and ADME profiles.

By leveraging HUMIMIC’s capabilities, pharmaceutical companies, academic institutions, and research organizations worldwide can make confident, data-driven decisions. Our technology significantly reduces development costs, accelerates the path to personalized medicine, and provides a powerful alternative to traditional animal testing—streamlining clinical trials and the entire drug discovery process.

With its flexible, user-friendly design, HUMIMIC enables precise in vitro toxicity and efficacy predictions, ensuring comprehensive safety assessments. Trusted by industry and academic leaders alike, TissUse is committed to revolutionizing research, empowering scientists to unlock new possibilities in drug development and beyond.